Form 4: GE HealthCare Director Lavizzo-Mourey Receives Restricted Stock Units

Director Risa J. Lavizzo-Mourey acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Summary

• On May 21, 2024, Risa J. Lavizzo-Mourey, a director of GE HealthCare Technologies Inc., was awarded 2,440 restricted stock units.
• These units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock upon settlement.
• Following the transaction, Lavizzo-Mourey directly owns 7,065 shares of GE HealthCare common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

• The award of restricted stock units aligns the director's interests with those of the shareholders.
• Director ownership of 7,065 shares demonstrates confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted stock units is tied to future events (annual meeting or a specific date).

Industry Context

This filing is a routine disclosure related to executive compensation and is common for publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice among publicly traded companies, including GE HealthCare's peers such as Siemens Healthineers and Philips.
• The vesting schedule, tied to the annual meeting or a specific date, is also typical in director compensation packages.
• The number of units granted is likely determined based on factors such as company performance, director responsibilities, and industry benchmarks for director compensation.

Stakeholder Impact

• The award of restricted stock units aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Next Steps

• The restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025.
• Settlement of vested restricted stock units will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.

Key Dates